Case report · 9 May 2025
CommentaryPublished 31 May 2021
4SCAR2.0 Treating Refractory B Cell Lymphomas: An advanced Technology Saves More Lives!
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
CAR-T cell therapy represents an innovative and effective therapy forpatientswithrefractory/relapsed Bcellmalignancies. However, many limitations remain with the currently approved CAR-T products, including antigen escape, CAR-T exhaustion in vivo, significant toxicity, and high cost, to name a few.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Medical Case Reports.
Perspective · 5 Feb 2025
A Cancer Research Partnership Training Program Evaluation
Case report · 2025
A Rare Cause of Sepsis in a Patient with Chronic Kidney Disease-A Case Report
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Cheng Jiao”
- BylineArticles whose byline prints “Liyuan Sheng”
- BylineArticles whose byline prints “Lung-Ji Chang”
